Type 1 Diabetes and Obstructive Sleep Apnea

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Chicago
Study ID
NCT06915831
Status
Recruiting
Apply to this trial

Conditions

  • Sleep Apnea, Obstructive
  • Type 1 Diabetes (T1D)

Eligibility Criteria

Sex
ALL
Age
18 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Continuous positive airway pressure (CPAP) — DEVICE
    All-night CPAP will be applied with bedtimes 23:00h to 7:00h.

Study Details

The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.

Key Dates

Start date
Nov 10, 2025
Status verified
Nov 2025
Primary completion
Aug 31, 2029
Completion
Aug 31, 2029

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER

Arms

  • No Intervention: Untreated
    No treatment for OSA
  • Active Comparator: Treated: Continuous positive airway pressure (CPAP) treatment
    Treatment for OSA by CPAP

Primary Outcome Measure

Glycemic variability [ Time Frame: Within 3 months of screening ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of ChicagoChicagoIllinois60637
Becky Tucker
[email protected]
773-702-2348

Find similar trials in Chicago, IL

By research site
University of Chicago· Chicago, IL

Related Studies